May 2019 - Volume 73 - Issue 5 - Contributor Index

Alphabetical Search
J
K
Q
U
V

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies

Schupp, Tobias; Behnes, Michael; Weiß, Christel; More

Journal of Cardiovascular Pharmacology. 73(5):272-281, May 2019.

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies

Schupp, Tobias; Behnes, Michael; Weiß, Christel; More

Journal of Cardiovascular Pharmacology. 73(5):272-281, May 2019.

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies

Schupp, Tobias; Behnes, Michael; Weiß, Christel; More

Journal of Cardiovascular Pharmacology. 73(5):272-281, May 2019.

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies

Schupp, Tobias; Behnes, Michael; Weiß, Christel; More

Journal of Cardiovascular Pharmacology. 73(5):272-281, May 2019.

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies

Schupp, Tobias; Behnes, Michael; Weiß, Christel; More

Journal of Cardiovascular Pharmacology. 73(5):272-281, May 2019.

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies

Schupp, Tobias; Behnes, Michael; Weiß, Christel; More

Journal of Cardiovascular Pharmacology. 73(5):272-281, May 2019.

Author:
Chen, Wei MA

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies

Schupp, Tobias; Behnes, Michael; Weiß, Christel; More

Journal of Cardiovascular Pharmacology. 73(5):272-281, May 2019.

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies

Schupp, Tobias; Behnes, Michael; Weiß, Christel; More

Journal of Cardiovascular Pharmacology. 73(5):272-281, May 2019.

Author:
Gao, Jing MS
Author:
Gemma, Marco MD
Author:
Hamano, Go MD

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies

Schupp, Tobias; Behnes, Michael; Weiß, Christel; More

Journal of Cardiovascular Pharmacology. 73(5):272-281, May 2019.

Author:
Li, Jing MD
Author:
liu, Ying MS

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies

Schupp, Tobias; Behnes, Michael; Weiß, Christel; More

Journal of Cardiovascular Pharmacology. 73(5):272-281, May 2019.

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies

Schupp, Tobias; Behnes, Michael; Weiß, Christel; More

Journal of Cardiovascular Pharmacology. 73(5):272-281, May 2019.

Author:
Pang, Daxin PhD

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies

Schupp, Tobias; Behnes, Michael; Weiß, Christel; More

Journal of Cardiovascular Pharmacology. 73(5):272-281, May 2019.

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies

Schupp, Tobias; Behnes, Michael; Weiß, Christel; More

Journal of Cardiovascular Pharmacology. 73(5):272-281, May 2019.

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies

Schupp, Tobias; Behnes, Michael; Weiß, Christel; More

Journal of Cardiovascular Pharmacology. 73(5):272-281, May 2019.

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies

Schupp, Tobias; Behnes, Michael; Weiß, Christel; More

Journal of Cardiovascular Pharmacology. 73(5):272-281, May 2019.

Author:
Tondi, Lara MD
Author:
Wang, Anbei MS
Author:
Wang, He MS
Author:
Wang, Ning PhD
Author:
Wang, Ying MA
Author:
Wei, Tong MD

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies

Schupp, Tobias; Behnes, Michael; Weiß, Christel; More

Journal of Cardiovascular Pharmacology. 73(5):272-281, May 2019.

Author:
Wu, Sipeng MD
Author:
Xie, Qihai MS
Author:
Yu, Biao MS
Author:
Yu, Tian PhD
Author:
Zhou, Weijun
Author:
Zotta, Elsa PhD
Show: